Anne Edelstein is an investor for Counterpoint Global. She joined Morgan Stanley in 2018 and has 13 years of investment experience. Prior to joining the firm, she was a Vice President and Equity Research Analyst at Bank of America Merrill Lynch (BAML) following life science tools and diagnostics. She previously covered semiconductors and specialty pharmaceuticals, also for BAML. Anne earned a B.A. in neuroscience at Hamilton College.